Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,500 shares, a drop of 90.7% from the February 28th total of 16,100 shares. Based on an average daily volume of 45,700 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.

Cocrystal Pharma Price Performance

NASDAQ COCP traded up $0.02 on Wednesday, hitting $1.50. 8,184 shares of the stock were exchanged, compared to its average volume of 29,361. The company has a market capitalization of $15.26 million, a PE ratio of -0.81 and a beta of 2.35. The business’s fifty day moving average is $1.83 and its 200 day moving average is $1.93. Cocrystal Pharma has a 52 week low of $1.35 and a 52 week high of $3.26.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Cocrystal Pharma in a report on Wednesday, January 22nd.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.